OpGen (OPGN) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock OPGN vs. UPHL, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, TALKW, and TOIIWShould you be buying OpGen stock or one of its competitors? The main competitors of OpGen include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry. OpGen vs. Its Competitors UpHealth Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute UpHealth (NYSE:UPHL) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Do institutionals & insiders have more ownership in UPHL or OPGN? 56.1% of UpHealth shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Comparatively, 43.8% of OpGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has higher valuation & earnings, UPHL or OPGN? OpGen has lower revenue, but higher earnings than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpHealth$130M0.00-$56.42M-$1.350.00OpGen$2.67M0.00-$32.67MN/AN/A Is UPHL or OPGN more profitable? UpHealth has a net margin of 0.00% compared to OpGen's net margin of -1,140.36%. Company Net Margins Return on Equity Return on Assets UpHealthN/A N/A N/A OpGen -1,140.36%N/A -287.58% Does the media prefer UPHL or OPGN? In the previous week, OpGen had 1 more articles in the media than UpHealth. MarketBeat recorded 1 mentions for OpGen and 0 mentions for UpHealth. OpGen's average media sentiment score of 1.00 beat UpHealth's score of 0.00 indicating that OpGen is being referred to more favorably in the news media. Company Overall Sentiment UpHealth Neutral OpGen Positive Which has more volatility & risk, UPHL or OPGN? UpHealth has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Comparatively, OpGen has a beta of -1.77, suggesting that its share price is 277% less volatile than the S&P 500. SummaryUpHealth beats OpGen on 5 of the 9 factors compared between the two stocks. Get OpGen News Delivered to You Automatically Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OPGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPGN vs. The Competition Export to ExcelMetricOpGenMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$1.23M$5.77B$9.93BDividend YieldN/AN/A6.67%4.52%P/E RatioN/AN/A75.6026.68Price / SalesN/A1.83555.18213.69Price / CashN/AN/A37.1158.92Price / BookN/A0.1111.446.09Net Income-$32.67M-$22.69M$3.28B$266.14M OpGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPGNOpGenN/AN/AN/AN/A$1K$2.67M0.00100Short Interest ↓UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750ACONWAclarionN/A$0.04-0.2%N/A+11.4%$0.00$62.95K0.007Positive NewsAONCAmerican Oncology NetworkN/A$11.00+2.8%N/A+217.7%$0.00$1.34B0.001,520Short Interest ↑Gap UpDHACWDigital Health AcquisitionN/A$0.02-36.1%N/A-36.0%$0.00N/A0.00N/AGap DownHigh Trading VolumeFMSFresenius Medical Care AG & Co. KGaA4.1502 of 5 stars$24.31-5.4%$27.80+14.4%+24.8%$0.00$20.63B19.921,384News CoverageAnalyst ForecastLFMDPLifeMDN/A$23.73+2.8%N/A+9.3%$0.00$245.56M0.00230Positive NewsGap DownOTRKPOntrakN/A$0.04+75.0%N/A-84.0%$0.00$10.84M0.00250Gap DownHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01-20.5%N/A-53.6%$0.00$1.46B0.00500Positive NewsGap DownTALKWTalkspaceN/A$0.09-5.6%N/A+40.0%$0.00$202.61M0.00500Positive NewsGap DownTOIIWOncology InstituteN/A$0.12-12.4%N/A+717.6%$0.00$424.38M0.00660Positive NewsShort Interest ↑Gap Down Related Companies and Tools Related Companies UPHL Competitors ACONW Competitors AONC Competitors DHACW Competitors FMS Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors TALKW Competitors TOIIW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OPGN) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OpGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OpGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPGN Stock Alerts